Pharmaceutical industry has withdrawn from the ‘antibiotic space.’ Is it time for research universities to step in?
The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive. (Twenty-three thousand die.) These experiences leave deep impressions not just on the patients but on their family and friends.
Michael Kinch, PhD, associate vice chancellor and director of the Center for Research Innovation in Business, is among that number. A few years ago his 12-year-old son suddenly became ill, so ill Kinch had to carry him into a nearby clinic in his arms. Because his son had a fever, the doctors at the clinic put him on first one and then a second antibiotic while they worked on a diagnosis.
They soon learned his son’s appendix had burst and he was septic. “Things moved so fast he was septic before he was symptomatic [for appendicitis],” Kinch said. His son was moved to an academic medical center where he had surgery and was put on four newer antibiotics.
When the lab tests for antibiotic susceptibility finally came in, they showed the pathogenic bacteria were susceptible to only two of the six antibiotics Kinch’s son had been given. Stunningly, the two that worked were the older drugs he had been given at the clinic. “I can only assume that if we had gone straight to the academic medical center, he might not have survived,” Kinch said.
“It’s not that my son had had extensive exposure to antibiotics,” Kinch explained carefully. “We’re all just colonized by resistant bacteria now.”
“Three weeks later I was asked to join a nonprofit organization working on new models for drug development, called the Institute for Life Sciences Collaboration,” Kinch said. “The institute was picking the therapeutic areas that would be their focus. “They were considering various exotic diseases, and I said, ‘Antibiotics.’”
Antibiotics are crashing.
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- Bill Clinton hospitalized, on antibiotics to fight infection in his bloodstreamon October 15, 2021 at 11:52 am
Former President Bill Clinton was admitted to the hospital on Tuesday after he was feeling fatigued. He was diagnosed with a urological infection that spread to his to his bloodstream. and is being ...
- Proteon Pharma to focus on Bacteriophages development as aternative to antibiotics in poultry industryon October 14, 2021 at 8:30 pm
Mumbai: Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA Poland, has recently announced that the company will focus on the development of bacteriophages as a ...
- Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?on October 14, 2021 at 1:30 pm
When—if ever—are antibiotics warranted before vascular closure devices are used? Turns out, opinions are mixed.
- Researchers Uncover Antibiotics’ Effects on the Gut Microbiomeon October 14, 2021 at 5:00 am
Researchers analyzed the effects of 144 antibiotics on our most common gut microbes. Their findings may lead to new personalized approaches to protect the gut microbiome.
- Scientists suggest a new approach to mitigating the collateral damage from antibioticson October 13, 2021 at 7:21 pm
Antibiotics help us to treat bacterial infections and save millions of lives each year. But they can also harm the helpful microbes residing in our gut, weakening one of our body's first lines of ...
- Tackling the collateral damage from antibioticson October 13, 2021 at 8:10 am
Antibiotics help us to get rid of bacterial infections – but they can also harm the helpful microbes residing in our guts. Researchers from the Typas group at EMBL Heidelberg and collaborators have ...
- Some antibiotics may kill 'helpful' gut bacteria, study findson October 13, 2021 at 8:01 am
Tetracyclines and macrolides, two commonly used classes of antibiotics, stop beneficial gut bacteria from growing and ultimately kill them, a study published Wednesday by Nature found.
- Proteon Pharma to focus on development of Bacteriophages as a sustainable alternative to antibiotics in poultry industryon October 12, 2021 at 7:00 am
Proteon Pharmaceuticals India - a subsidiary of Proteon Pharmaceuticals SA Poland, today announced it will focus on the development of bacteriophages as a sustainable alternative to ...
- Is excessive use of antibiotics causing harm to you?on October 8, 2021 at 7:47 am
Nowadays, whenever we consult a doctor for flu, fever, common cold, or other infections, we are usually prescribed antibiotics. Usually, the entire ...
- Inhaled Antibiotics Market Report 2021 Size with Segments Analysis, Competitive Landscape, Top Countries Data and Growth Opportunities to 2027on October 4, 2021 at 11:06 pm
Global “Inhaled Antibiotics Market” Size, Status and Growth Forecast to 2027: The Inhaled Antibiotics Market report ...
via Bing News